Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 3/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.30 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.30 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.30 |
| ▸ | CTSD | P07339 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8946195 | 0.84 | HSD11B1 (0.31) | HSD11B1 | |
| Dazepinil SCHEMBL499286 | 0.82 | CHRNB2 (0.40) | CYP2D6MEN1RECQLKMT2A | |
| SCHEMBL8946162 | 0.82 | HSD11B1 (0.30) | HSD11B1CTSD | |
| SCHEMBL11266015 | 0.80 | MAOA (0.43) | CYP2D6MEN1RECQLKMT2A | |
| SCHEMBL8945898 | 0.79 | CYP19A1 (0.35) | CYP2D6MEN1RECQLKMT2ACTSD | |
| SCHEMBL8945889 | 0.78 | CHRNB2 (0.48) | MEN1KMT2A | |
| SCHEMBL9582495 | 0.78 | ALDH1A1 (0.41) | MEN1RECQLKMT2A | |
| SCHEMBL9583299 | 0.78 | MAOB (0.42) | KMT2A | |
| SCHEMBL11282542 | 0.77 | MAOB (0.44) | MEN1KMT2A | |
| SCHEMBL9583012 | 0.77 | MEN1 (0.39) | MEN1RECQLKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5510346-A | ANTIDEPRESSANTS, ANTIANXIETY AGENTS | HOECHST MARION ROUSSEL, INC. (US) | 1996-04-23 | — | — | US | disclosed |
| US-5292760-A | 4-heteroaryl-1,3-benzodiazepines and 2-substituted-α-(heteroaryl)benzeneethanamines | HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) | 1994-03-08 | — | — | US | disclosed |
| EP-0322582-A2 | 4-Heteroaryl-1,3-Benzodiazepines and 2-substituted-alpha-(heteroaryl)benzeneethanamines, a process for their preparation and their use us medicaments | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1989-07-05 | — | — | EP | disclosed |